L-Ornithine: Research, Dosing, and Where to Buy in 2026
A research-first profile for L-Ornithine (lornitine), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
L-Ornithine is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for L-Ornithine, each linked to its source.
- Also indexed as lornitine.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is L-Ornithine?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
L-Ornithine Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy L-Ornithine in 2026
No tracked vendor recommendations for L-Ornithine yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about L-Ornithine. Each line links to the original source.
- "When we conducted an integration analysis on the risk of adverse events, the difference between those with and without L-Orn supplementation in the risk of gastrointestinal disorders was 0.00 (95% confidence interval: ±0.02, P = 1.00), so no significant effects were observed." · Yang H et al, 2025 PubMed
- "Higher rates of improvement in grade of HE (92.5% vs." · Jain A et al, 2022 PubMed
- "66%, p < 0.001), lower time to recovery (2.70 ± 0.46 vs." · Jain A et al, 2022 PubMed
- "3.00 ± 0.87 days, p = 0.03), and lower 28-day mortality (16.4% vs." · Jain A et al, 2022 PubMed
- "41.8%, p = 0.001) were seen in the LOLA group as compared with placebo." · Jain A et al, 2022 PubMed
Research and Studies
8 PubMed-indexed papers reference L-Ornithine. Top 8 shown.
Legal Status
L-Ornithine is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is L-Ornithine FDA-approved?
L-Ornithine is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on L-Ornithine?
8 PubMed-indexed paper(s) reference L-Ornithine in our current research feed. See the Research and Studies section above for citations.